IGFFX | VTSNX | IGFFX / VTSNX | |
Total Expense Ratio | 0.65 | 0.06 | 1,083% |
Annual Report Gross Expense Ratio | 0.65 | 0.06 | 1,083% |
Fund Existence | 17 years | 15 years | - |
Gain YTD | 18.360 | 14.889 | 123% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 17B | 493B | 3% |
Annual Yield % from dividends | 2.37 | 2.91 | 81% |
Returns for 1 year | 11.95 | 10.74 | 111% |
Returns for 3 years | 30.99 | 22.77 | 136% |
Returns for 5 years | 44.10 | 38.60 | 114% |
Returns for 10 years | 41.89 | 42.68 | 98% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBC | 19.76 | 0.18 | +0.91% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
TDIV | 83.73 | 0.16 | +0.19% |
First Trust NASDAQ Technology Div ETF | |||
QJUN | 28.68 | -0.28 | -0.97% |
FT Vest Nasdaq-100 Buffer ETF - Jun | |||
OARK | 7.89 | -0.16 | -1.99% |
YieldMax ARKK Option Income Strategy ETF | |||
BITQ | 17.21 | -0.67 | -3.75% |
Bitwise Crypto Industry Innovators ETF |